MedlyPeds App for Heart Disease

DB
Overseen ByDiana Balmer-Minnes
Age: < 65
Sex: Any
Trial Phase: Academic
Sponsor: The Hospital for Sick Children
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

SickKids and UHN have developed MedlyPeds which is a smart phone application designed to remotely monitor patients with heart disease. This is a feasibility study which will enroll up to 30 patients with different types of heart disease to see which patient types may benefit the most from MedlyPeds if it were to be used for clinical monitoring. The study is gathering feedback about the app from patients, parents and clinicians to confirm how it needs to be modified to better serve the purpose in a future trial.

Are You a Good Fit for This Trial?

Inclusion Criteria

1. Consent provided.
I have pulmonary hypertension.
I am between 8 and 18 years old.
See 5 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants use the MedlyPeds app for remote monitoring of heart disease

3 months
Remote monitoring via app

Follow-up

Participants complete quality of life questionnaires and provide feedback on the app

4 weeks
1 visit (in-person or virtual)

What Are the Treatments Tested in This Trial?

Interventions

  • MedlyPeds App

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: MedlyPedsExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

The Hospital for Sick Children

Lead Sponsor

Trials
724
Recruited
6,969,000+

University Health Network, Toronto

Collaborator

Trials
1,555
Recruited
526,000+